RAC1 and breast carcinoma: This active FAK–Src complex activates Ras-related C3 botulinum toxin substrate 1 (Rac1) by recruiting and phosphorylating the p130 Cas scaffold protein (p130 Crk-associated substrate, known as breast cancer anti-estrogen resistance 1 [Bcar1]) [25].